Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x100px

Organisation › Details

European Commission (EC)

	Group	EU (govt)
	Predecessor	EG-Kommission

	Region	Brussels
	Country	Belgium
	City	n. a. Brussels
		Address record changed: 2011-11-27

Basic data	Employees	n. a.


		Record changed: 2024-07-13

Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x200px

More documents for EU (govt)

[1] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
[2] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
[3] Integra Therapeutics S.L.. (7/16/24). "Press Release: Integra Therapeutics to Receive up to €10.5 Million from European Commission for Its FiCAT Advanced Therapies Platform". Lausanne & San Francisco, CA....
[4] Biovance Capital Partners. (7/9/24). "Press Release: Biovance Capital Partners Announces First Closing of Its New Biotech Fund at €51 million". Lisbon....
[5] Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert....
[6] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
[7] Biovance Capital Partners. (5/16/24). "Press Release: Biovance Capital Is the First Ever Investment in a Portuguese Life Sciences VC Fund by the EIF"....
[8] Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC"....
[9] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
[10] SolasCure Ltd.. (11/3/23). "Press Release: SolasCure Awarded Prestigious European Innovation Council’s Accelerator Grant"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]